Page last updated: 2024-09-03

dx 9065a and Coronary Heart Disease

dx 9065a has been researched along with Coronary Heart Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armstrong, PW; Becker, RC; Bovill, EG; Dyke, CK; Dzavik, V; Gardner, LH; Gerstenblith, G; Harrington, RA; Hasselblad, V; Hochman, JS; Kleiman, NS; Kunitada, S; Lincoff, AM; Robertson, TL; Shimoto, Y; Zillman, LA	1

Trials

1 trial(s) available for dx 9065a and Coronary Heart Disease

Article	Year
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. Circulation, 2002, May-21, Volume: 105, Issue:20 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Cohort Studies; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa; Factor Xa Inhibitors; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Infusions, Intravenous; International Normalized Ratio; Linear Models; Male; Middle Aged; Naphthalenes; Partial Thromboplastin Time; Propionates; Prothrombin Time; Time Factors	2002

Article

Year

First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.

Circulation, 2002, May-21, Volume: 105, Issue:20

Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Cohort Studies; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Factor Xa; Factor Xa Inhibitors; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Infusions, Intravenous; International Normalized Ratio; Linear Models; Male; Middle Aged; Naphthalenes; Partial Thromboplastin Time; Propionates; Prothrombin Time; Time Factors

2002